To assess the benefits and harms of tenofovir-based antiviral combination regimens for hepatitis B virus (HBV) for the prevention of mother-to-child transmission of HBV, in HIV-positive pregnant women co-infected with HBV.
This is a protocol.
Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus
You may also be interested in:
- Hepatitis B immunoglobulin (HBIG) during pregnancy for the prevention of mother-to-child transmission of hepatitis B virus (HBV)
- Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection
- Mother-to-child transmission (MTCT) of HIV is the primary way that children become infected with HIV. More than 2000 children worldwide are infected in this way every day.
- Interventions for reducing the risk of mother-to-child transmission of HIV infection
- Vaginal disinfection for preventing mother-to-child transmission of HIV infection